HOME >> MEDICINE >> NEWS
Swedish trials suggest modest benefit for screening mammography

New data with longer follow-up from four Swedish trials published in this weeks issue of THE LANCET suggests there may be a modest benefit from screening mammography for women aged 55 years or over.

Considerable debate surrounds the issue of screening mammography and its possible benefits. A research letter by Ole Olsen and Peter Gotzsche (Lancet 2001; 358: 1340-42) concluded that there was no reliable evidence from randomised trials to support the benefit of screening mammography. Lennarth Nystrom and colleagues from the University of Umea, Sweden, present new data updating the overview of four Swedish randomised controlled trials on mammography screening up to and including 1996. The study also contains data from the trials that have not been presented before.

The trials include data for about 247,000 women, who were followed-up by record linkage to the Swedish Cancer and Cause of Death Registers. The relative risks for breast cancer death and death from all causes were calculated for women given screening mammography and those not invited for screening (the control groups in the four trials).

Average follow-up time for the trials was 15.8 years. There were 511 breast cancer deaths in 1 864 770 women-years in the groups given mammography, and 584 breast cancer deaths in 1 688 440 women-years in the control groupsresulting in a significant 21% reduction in breast cancer mortality for women given screening mammography. The reduction was greatest (33%)in the age group 6069 years at entry to the trials. There were statistically significant effects in the age groups 5559, 6064, and 6569 years, but there was only a small relative risk reduction (5%) in women aged 50-54 years. The benefit in terms of cumulative breast cancer mortality started to emerge at about 4 years after randomisation and continued to increase to about 10 years. There was no significant difference in death from all causes between screening and control groups.

Lenna
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
14-Mar-2002


Page: 1 2

Related medicine news :

1. Promising new strategy for Swedish medical research
2. Hopkins begins human trials with donor adult stem cells to repair muscle damaged from heart attack
3. US attempting to flout ethical practice for patient trials abroad
4. New trials for counseling caregivers and patients with Alzheimers begin
5. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
6. New ITN Scholars Program provides junior faculty opportunity to develop clinical trials expertise
7. OHSU researcher says FDA could broaden access to results of clinical drug trials
8. Success of experimental herpes vaccine builds momentum for human clinical trials
9. Re-analysis of large trials shows greatest benefit of chemotherapy in ER-negative tumors
10. Establishing pediatric stroke trials
11. NIAID seeks applicants to lead revamped HIV/AIDS clinical trials networks

Post Your Comments:
(Date:10/31/2014)... one out of four older Americans say that either ... unwanted medical treatment, according to the latest issue of ... Aging Report ( PP&AR ), which goes on ... when they fail to honor patients, end-of-life health care ... Illness Care: Issues and Options ," features 12 articles ...
(Date:10/31/2014)... Gold Medal Wine Club is making ... gifts for the wine novice and enthusiasts on their lists ... Special , which Early Bird shoppers receive discounts as high ... membership. , Gift Givers must place their orders before ... discounts, Gold Medal Wine Club adds more value to its ...
(Date:10/31/2014)... York (PRWEB) October 31, 2014 North ... Eye in Garden City, Long Island and the addition ... their medical staff, according to North Shore Eye Care ... the Emeritus Acting Chairman of the Department of Ophthalmology ... successful practice in Garden City for more than 30 ...
(Date:10/31/2014)... combination that can trigger the self-destruct process in lung ... according to research that will be presented at the ... next week*. , When healthy cells are no longer ... self destruction. But cancer cells swerve away from this ... grow out of control – causing tumours to form. ...
(Date:10/31/2014)... 31, 2014 FindSurrogateMother.com conveys ... gifts of life — building a family through surrogacy. ... mothers and donors with hopeful intended parents in turn ... , It’s a collective aptitude of surrogate mothers, intended ... and fertility clinics that help provide these connections — ...
Breaking Medicine News(10 mins):Health News:Advance directives can benefit patients, families, and health care system 2Health News:Gold Medal Wine Club now offering Early Bird Gift Giving Special for Holidays 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 3Health News:Scientists trigger self-destruct switch in lung cancer cells 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 3
(Date:10/31/2014)...  Zebra Imaging, Inc., the world,s foremost provider ... strategic partnership with the Zygote Media Group Inc., ... biomedical models for animation and visual effects, to ... maintains the world,s most comprehensive library of accurate ... development of high-end solid 3D anatomy models for ...
(Date:10/31/2014)... Oct. 31, 2014  Australian biopharmaceutical company Specialised Therapeutics ... (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine, will be ... with metastatic pancreatic cancer from 1 November. ... is the 5 th most common cause of ... cancer deaths, with the lowest 5-year survival of all ...
(Date:10/31/2014)... , October 31, 2014 ... a clinical-stage pharmaceutical company focused on the development ... company will host a conference call to discuss ... trial of ORMD-0801, the company,s proprietary oral insulin ... November 3, 2014 at 10:00 a.m. Eastern time. ...
Breaking Medicine Technology:Zebra Imaging and Zygote Media Partner to Bring 3D Visualization to the Medical Community 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 3Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 4Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 5Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 6Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 7Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 8Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3
Cached News: